Shilpa Pharma Lifesciences’ Raichur API facility clears second consecutive FDA inspection with no observations Read more
Granules India’s Gagillapur facility classified as “Official Action Indicated” following US FDA Inspection Read more
Wanbury’s Patalganga manufacturing facility clears U.S. FDA inspection with zero observations Read more
